
FDA's Peptide "Interim Access Policy" Is Not Amnesty: The Federal Criminal Exposure Florida Compounders, Clinics and Peptide Sellers Still Face
Selling or compounding BPC-157 in Florida? FDA's interim access notice is not a rule, and 21 U.S.C. 331 and wire fraud exposure remain. See where you stand.












